Depression linked to E-cigarettes and cigarette use among college students

Jul.15.2022
Depression linked to E-cigarettes and cigarette use among college students
Depression linked to tobacco use among college students, according to study in Psychiatry Research Communications.

A study published in the Journal of Psychiatric Research found a positive correlation between depression and tobacco product use, including electronic and traditional cigarettes, among college students.


This study analyzed data from the Fall 2020 cohort of the Healthy Minds Study, which collected information on the psychological health of undergraduate and graduate students, as well as sociodemographic covariates and other relevant factors. The online survey was distributed to 36 universities across the United States between September and December 2020. Five of these universities included drug use in the survey, resulting in a sample size of 2,115 for this study.


Attendees reported on individuals who exclusively use e-cigarettes, exclusively use traditional cigarettes, and those who use a combination of both. The symptoms of depression were measured using the Patient Health Questionnaire-9 (PHQ-9) for the participants. The PHQ-9 questionnaire scores the answers on a scale ranging from 0 to 27, with scores above 5 indicating possible depression.


The study measures societal norms surrounding tobacco use and perceptions of risks associated with tobacco use. In order to gauge societal norms, participants were asked to estimate the percentage of college students who smoke. Responses to questions about tobacco risks were measured on a scale of 1 to 4, with 1 indicating "no risk" and 4 indicating "high risk.


Using logistic regression analysis, this study examines the social norms of tobacco use among individuals with symptoms of depression, perceived risk of smoking, and those who use both traditional cigarettes and e-cigarettes.


The average age of participants was 23.41±7.84 years, with 43.8% being female and 85.6% being white. Participants reported that in the past 30 days, 22.38% only used e-cigarettes, 7.89% only used traditional cigarettes, and 2.72% used a combination of both.


A study has found that 33.1% of participants met the criteria for possible depression, with an average score of 8.00 ± 6.33. The levels of depression were higher among all groups who used tobacco products: those who only used e-cigarettes (OR, 1.08; 95%CI, 1.06-1.10), those who only smoked traditional cigarettes (OR, 1.09; 95%CI, 1.06-1.12), and those who used both (OR, 1.05; 95%CI, 1.00-1.10).


Participants reported medium risks associated with smoking and vaping, with average scores of 3.26 ± 1.01 and 2.85 ± 0.98, respectively. The perceived social norms related to the use of electronic cigarettes (OR, 1.01; 95% CI 1.00-1.02) and cigarettes (OR, 1.02; 95% CI, 1.00-1.03) were higher and associated with increased use of these tobacco products.


Most participants in the study were white students, so the results may not be representative. Although the researchers emphasized the confidentiality of the responses, students may have underreported their tobacco use.


Overall, researchers have concluded that there is a link between depression and both e-cigarettes and traditional cigarettes. They have found that the likelihood of using e-cigarettes and traditional cigarettes is positively associated with the likelihood of depression.


The researchers stated that gaining further knowledge on psychosocial and mental health related factors could provide valuable information in understanding the smoking habits and associated risks in college students. This understanding can guide the development of smoking cessation policies.


I'm sorry, but without any text to translate, I cannot provide a response.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
At the 2026 New Approaches Summit in New York, FDA Center for Tobacco Products Director Bret Koplow said the PMTA pathway is “predicated on tobacco harm reduction.” He outlined four CTP priorities: youth prevention, helping adults quit or switch to lower-risk products, improving relative-risk communication, and reducing unauthorized products. Koplow also addressed flavored e-cigarettes, public risk perceptions, industry credibility and efforts to make PMTA reviews more efficient and predictable.
Sep.26
Why AIRSCREAM Built its European Production Hub for Regulated Market Growth
Why AIRSCREAM Built its European Production Hub for Regulated Market Growth
AIRSCREAM’s production hub in the Czech Republic brings nicotine pouch manufacturing, e-liquid bottling, product documentation, warehousing and international logistics into one operation, giving brands and commercial partners a practical platform from which to launch, expand and enter new markets.
Market
Sep.16 by 2Firsts Perspectives
U.S. Rep. Krishnamoorthi Questions FDA Over Planned PMTA Rewrite, Seeks Communications With Altria and Reynolds
U.S. Rep. Krishnamoorthi Questions FDA Over Planned PMTA Rewrite, Seeks Communications With Altria and Reynolds
U.S. Rep. Raja Krishnamoorthi on Oct. 6 questioned the FDA over its plan to reassess and potentially replace the 2021 PMTA regulatory framework, asking the agency to identify provisions it may change or eliminate, state whether current scientific evidentiary standards will be maintained, and disclose communications with Altria, Reynolds and other parties challenging the rule. Krishnamoorthi led a congressional investigation into JUUL and youth vaping in 2019 and has since remained active on e-cigarette regulation and enforcement.
Regulations
Oct.08
Charlie’s Bets on Age-Gating and 678 PMTA Assets as U.S. Vape Enforcement Landscape Shifts
Charlie’s Bets on Age-Gating and 678 PMTA Assets as U.S. Vape Enforcement Landscape Shifts
Charlie’s Holdings said in its latest shareholder letter that it is moving to commercialize PACHA products and monetize its PMTA assets as the FDA changes enforcement priorities for unauthorized ENDS products. Thirty PACHA SKUs were previously tentatively identified for a proposed public list of products that the FDA generally does not intend to prioritize for enforcement. Charlie’s is also preparing test-market sales of age-gated flavored disposables and says it currently holds 678 PMTA-related product assets while seeking additional strategic transactions and partnerships.
Sep.11
Swedish-Founded Nicotine Pouch Retailer GotPouches Shifts to U.S.-Based Operations, Reaching Over 25 States
Swedish-Founded Nicotine Pouch Retailer GotPouches Shifts to U.S.-Based Operations, Reaching Over 25 States
Swedish-founded online nicotine pouch retailer GotPouches has completed the localization of its U.S. operations under UpNorth Retail LLC, with corporate operations in Franklin, Tennessee, domestic fulfillment from Nashville and U.S.-based customer support. The company says its catalog covers more than 20 nicotine pouch brands and it currently serves customers in more than 25 U.S. states.
Sep.18
Product | PMI Launches TEREA Black Mint Pearl in Japan, Adding First Capsule Variant to Black Range With Nationwide Rollout From October 19
Product | PMI Launches TEREA Black Mint Pearl in Japan, Adding First Capsule Variant to Black Range With Nationwide Rollout From October 19
Philip Morris Japan (PMJ) launched TEREA Black Mint Pearl on October 15, 2026, introducing the first capsule-equipped heated tobacco stick in the TEREA Black range for IQOS ILUMA devices. The product combines a strong menthol profile with a crushable mint capsule and is priced at ¥640 per 20-stick pack, including tax. Sales began at four IQOS stores and selected retail partners on October 15, with distribution expanding to convenience stores and other tobacco retailers nationwide from October 19. The launch brings Japan's TEREA portfolio to 28 variants, including 21 menthol-related products, or 75% of the range.
product
Oct.16 by 2Firsts Perspectives